John Theurer Cancer Center, Hackensack University Medical Center | Strategic Alliance Partners

Immunotherapy has changed the face of cancer treatment, but requires appropriate irAE management to reach full potential.

Gabriella Magarelli, MSN, ACNP-BC, AOCNP, reflects on lessons learned caring for patients with cancer and COVID-19.

Special protocols are required to ensure the safety of patients undergoing bone marrow transplants.

Oral decitabine, an oral fixed-dose of combination decitabine and CDA inhibitor cedazuridine, is an FDA-approved therapy for patients with lower-risk myelodysplastic syndromes.

The chair of the Institute of Pain and Palliative Care explains how the holistic approach of palliative care makes it a unique treatment modality.

The chair of the Institute of Pain and Palliative Care explains how patients with cancer may improve their treatment outcomes with palliative care.

Joe Contreras, MD, chair of the Institute of Pain and Palliative Medicine, explains how some common misconceptions may be hindering patients from receiving potentially outcome-improving palliative care.

For National Hospice and Palliative Care Awareness Month, Joe Contreras, MD, spoke to Oncology Nursing News® about some common misconceptions between the 2 and how oncology nurses can more effectively speak with their patients about palliative care.